Ba253BINEB

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 3

Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02182635

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1998-08-31Updated: 2014-07-11

A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma

CompletedNCT02182661

Boehringer IngelheimAsthma

Start: 1998-07-31Updated: 2014-07-11

Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02182583

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1998-10-31Updated: 2014-07-11